Exploring the data of life during the BioAlps Networking Day with the Datarium exhibition created by the Swiss Institute of…

Neurosterix, a Geneva-based clinical-stage biotechnology company developing novel, selective allosteric modulators for neuropsychiatric disorders, announced the closing of a $105…

Changing eating and drinking habits doesn’t have to start with restriction. Bewe Lab, a spinoff of the University of Fribourg…

The Swiss Biotech Association has appointed Nicolas Durand as CEO, effective 1 January 2027, and Odile Rundquist as Chief Strategy & Growth Officer, as…

Based in Monthey (VS) since 2003, ExcellGene last week celebrated 25 years of biotechnology innovation also marking the leadership transition…

Geneva University Hospitals (HUG) has received over CHF 1 million from the Swiss National Science Foundation to take part in…

The 2026 CSS Health Study shows chatbots are fast becoming part of how people in Switzerland manage their health, from…

The Valais-based start-up is accelerating the development of its lead candidate in partnership with the Geneva University Hospitals (HUG) and…

The EPFL spin-off Apolarion has obtained CHF 150,000 from Venture Kick to advance a chemical-free seed treatment technology powered by…

Lonza, the largest Swiss Health Valley🇨🇭 company, signs an agreement with Merck KGaA to acquire five CDMO manufacturing sites and…

Nagi Bioscience, an EPFL spin-off based at EPFL Innovation Park, has announced a new partnership with InVirtuoLabs, based in Ticino,…

Distalmotion, a global MedTech company based à Biopôle-Lausanne and focused on expanding access to robotic surgery in outpatient settings, announced…